<div>A novel preclinical study by Keck Medicine of USC researchers, published in Arthritis &amp; Rheumatology, reveals that a potential new opioid medication may have the ability to slow the progression of osteoarthritis while being less addictive than commonly prescribed opioid drugs.</div>